We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Edwards Lifesciences Corp | NYSE:EW | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.275 | 0.32% | 85.335 | 86.95 | 85.20 | 85.85 | 1,259,052 | 20:44:15 |
From May 2022 to May 2024
By Colin Kellaher
Edwards Lifesciences Corp. on Thursday said Michael Mussallem, who has been chairman and chief executive of the medical-device maker since its spinoff from Baxter International Inc. in 2000, plans to retire as CEO in May.
The Irvine, Calif., company said Bernard Zovighian, currently corporate vice president and general manager for its transcatheter mitral and tricuspid therapies business, will become president on Jan. 1 and succeed Mr. Mussallem as CEO on May 11 in connection with the annual shareholder meeting.
Edwards said Mr. Mussallem, who recently turned 70, will stand for election as non-executive chairman at the annual meeting.
Mr. Zovighian joined Edwards in 2015.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
December 08, 2022 08:41 ET (13:41 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Edwards Lifesciences Chart |
1 Month Edwards Lifesciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
